Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Lal Pathlabs Ltd

₹ 2,889 -1.45%
11 Jul 9:07 a.m.
lalpathlabs.com BSE: 539524 NSE: LALPATHLAB
About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

Key Points

Largest Diagnostic Chain
It is the largest diagnostics chain with a Pan-India presence. The company has 75 years of experience in the field of diagnostics and has served 131 million patients in the last five years. Its test offerings range from basic preventive health packages like SwasthFit to the most advanced investigations, including Comprehensive Genomic Profiles, Myeloid testing for Hematological Malignancies, and Amyloid Typing Solutions. [1] [2]

Website BSE NSE
  • Market Cap ₹ 24,203 Cr.
  • Current Price ₹ 2,889
  • High / Low ₹ 3,654 / 2,294
  • Stock P/E 49.5
  • Book Value ₹ 260
  • Dividend Yield 0.83 %
  • ROCE 28.9 %
  • ROE 24.3 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 11.3 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
486 503 534 489 491 541 601 539 545 602 660 597 603
364 385 390 376 375 395 424 398 401 432 458 443 434
Operating Profit 121 118 144 113 116 146 178 141 145 170 202 154 169
OPM % 25% 23% 27% 23% 24% 27% 30% 26% 27% 28% 31% 26% 28%
12 8 9 10 14 14 18 18 18 21 22 25 26
Interest 12 8 11 9 9 8 8 7 7 6 6 5 5
Depreciation 38 36 39 38 38 35 36 36 37 35 35 36 36
Profit before tax 84 81 103 76 83 118 152 116 120 150 183 138 153
Tax % 26% 28% 30% 30% 32% 29% 27% 29% 28% 28% 29% 29% -1%
62 58 72 54 57 84 111 82 86 108 131 98 156
EPS in Rs 7.35 6.92 8.60 6.33 6.80 9.90 13.09 9.74 10.12 12.75 15.46 11.57 18.52
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
558 660 791 912 1,057 1,203 1,330 1,581 2,087 2,017 2,227 2,461
419 504 582 675 793 910 987 1,145 1,526 1,527 1,617 1,764
Operating Profit 139 156 210 238 264 294 344 436 561 490 609 698
OPM % 25% 24% 26% 26% 25% 24% 26% 28% 27% 24% 27% 28%
8 12 20 27 31 46 55 51 52 42 69 91
Interest 0 0 0 1 1 1 15 16 30 38 29 22
Depreciation 27 28 28 28 33 38 73 77 108 150 144 142
Profit before tax 119 140 201 237 261 301 310 394 475 344 505 625
Tax % 33% 31% 34% 34% 34% 33% 27% 25% 26% 30% 28% 21%
80 96 133 156 172 200 228 296 350 241 362 492
EPS in Rs 148.27 17.51 15.99 18.61 20.49 23.90 27.11 34.99 41.37 28.65 42.85 58.28
Dividend Payout % 7% 9% 15% 16% 22% 25% 44% 57% 29% 21% 0% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 13%
3 Years: 6%
TTM: 11%
Compounded Profit Growth
10 Years: 18%
5 Years: 17%
3 Years: 12%
TTM: 37%
Stock Price CAGR
10 Years: %
5 Years: 10%
3 Years: 12%
1 Year: -1%
Return on Equity
10 Years: 23%
5 Years: 22%
3 Years: 20%
Last Year: 24%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 54 55 83 83 83 83 83 83 83 83 83 84
Reserves 151 260 425 512 705 862 949 1,162 1,418 1,583 1,766 2,089
28 27 0 0 0 0 0 150 533 420 247 157
119 134 118 95 128 145 341 265 309 297 357 383
Total Liabilities 352 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,454 2,713
140 150 166 152 208 209 413 447 1,369 1,305 1,228 1,168
CWIP 0 1 4 18 10 3 11 10 15 5 6 3
Investments 9 38 64 106 145 185 164 59 65 150 114 327
203 286 391 414 554 694 786 1,144 893 923 1,107 1,215
Total Assets 352 475 625 690 916 1,091 1,374 1,661 2,343 2,383 2,454 2,713

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
98 122 159 171 197 219 284 398 447 456 535 569
-89 -113 -163 -137 -172 -100 -26 -212 -449 -287 -24 -303
-10 -1 0 -32 13 -55 -190 -139 136 -283 -414 -334
Net Cash Flow -2 8 -5 2 37 64 67 48 134 -114 97 -68

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 16 17 17 17 14 16 14 15 15 13 13 13
Inventory Days 37 31 33 44 40 70 39 38 28 30 27
Days Payable 90 89 97 106 111 144 132 107 127 151 151
Cash Conversion Cycle 16 -35 -42 -47 -47 -55 -60 -78 -54 -87 -108 -110
Working Capital Days -26 -9 27 19 17 0 -19 -17 -14 -19 -22 -22
ROCE % 60% 48% 47% 43% 38% 35% 32% 33% 29% 18% 25% 29%

Shareholding Pattern

Numbers in percentages

10 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
55.05% 55.04% 55.04% 55.03% 55.01% 54.61% 54.60% 54.60% 54.60% 53.92% 53.91% 53.91%
22.37% 23.26% 25.80% 24.89% 23.27% 24.35% 25.36% 26.15% 25.43% 26.82% 26.82% 23.90%
6.52% 6.27% 6.20% 6.56% 8.34% 8.85% 9.27% 9.40% 12.42% 12.60% 12.88% 15.79%
0.00% 0.00% 0.00% 0.00% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29%
15.46% 14.84% 12.38% 13.01% 12.65% 11.48% 10.12% 9.24% 6.95% 6.02% 5.82% 5.84%
0.60% 0.58% 0.56% 0.51% 0.44% 0.41% 0.37% 0.32% 0.30% 0.33% 0.28% 0.27%
No. of Shareholders 1,84,5081,71,6021,79,6361,80,1631,74,4441,60,6791,49,9011,46,7411,31,1891,16,6061,16,2361,15,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls